IMC

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging

Retrieved on: 
Monday, April 8, 2024
Automation, B cell, LIMS, SAN, Biomarker, Research, Acquisition, Doctor of Philosophy, Hyperion, Standard BioTools, IMC, Medical imaging

Increased adoption of multiplexed tissue imaging as a spatial biology tool is driving a need for higher sample throughput.

Key Points: 
  • Increased adoption of multiplexed tissue imaging as a spatial biology tool is driving a need for higher sample throughput.
  • Standard BioTools™ has developed new groundbreaking capabilities to image tissue samples at never-before-seen speeds and automation, accelerating and deepening insight generation.
  • Novel whole slide imaging using Imaging Mass Cytometry (IMC™) offers a unique opportunity to garner the most data out of limited samples with up to 10 times higher throughput than cyclic immunofluorescent imaging.
  • This walk-away automation option eliminates manual error, reduces hands-on time and enables standardization with barcoded slide identification and LIMS connectivity.

IDTechEx Explores Technology Trends in Dielectric Materials for Next Generation 2.5D and 3D Semiconductor Packaging

Retrieved on: 
Wednesday, March 27, 2024
Temperature, Communication, Silicon dioxide, L/S, Polymer, Copper, CTE, Coefficient, CMP, TCB, Intermetallic, RDL, Miniaturization, Ecosystem, Young, Viscoelasticity, IMC, Printed circuit board

This article explores the technology trends in dielectric materials for both 2.5D and 3D packaging, with insights drawn from IDTechEx's market report on the topic, " Materials and Processing for Advanced Semiconductor Packaging 2024-2034 ".

Key Points: 
  • This article explores the technology trends in dielectric materials for both 2.5D and 3D packaging, with insights drawn from IDTechEx's market report on the topic, " Materials and Processing for Advanced Semiconductor Packaging 2024-2034 ".
  • However, traditional inorganic dielectric materials like SiO2, though capable of achieving fine L/S, suffer from high dielectric constants (Dk=3.9) and are tied to the Si manufacturing technique.
  • Organic dielectric materials emerge as promising alternatives for advanced semiconductor packaging, offering lower dielectric constants and cost advantages.
  • Finally, the report includes a 10-year market forecast for Organic Dielectric Advanced Semiconductor Packaging, providing industry perspectives on market growth and trends.

IDTechEx Explores Technology Trends in Dielectric Materials for Next Generation 2.5D and 3D Semiconductor Packaging

Retrieved on: 
Wednesday, March 27, 2024
Temperature, Communication, Silicon dioxide, L/S, Polymer, Copper, CTE, Coefficient, CMP, TCB, Intermetallic, RDL, Miniaturization, Ecosystem, Young, Viscoelasticity, IMC, Printed circuit board

This article explores the technology trends in dielectric materials for both 2.5D and 3D packaging, with insights drawn from IDTechEx's market report on the topic, " Materials and Processing for Advanced Semiconductor Packaging 2024-2034 ".

Key Points: 
  • This article explores the technology trends in dielectric materials for both 2.5D and 3D packaging, with insights drawn from IDTechEx's market report on the topic, " Materials and Processing for Advanced Semiconductor Packaging 2024-2034 ".
  • However, traditional inorganic dielectric materials like SiO2, though capable of achieving fine L/S, suffer from high dielectric constants (Dk=3.9) and are tied to the Si manufacturing technique.
  • Organic dielectric materials emerge as promising alternatives for advanced semiconductor packaging, offering lower dielectric constants and cost advantages.
  • Finally, the report includes a 10-year market forecast for Organic Dielectric Advanced Semiconductor Packaging, providing industry perspectives on market growth and trends.

Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US

Retrieved on: 
Thursday, March 7, 2024
CHIM, Placebo, USD, Otto, ETEC, Diarrhea, Gastrointestinal tract, Food, Treatment, BLA, Enterotoxigenic Escherichia coli, Bacteria, ASX, Food and Drug Administration, Patient, IMC, Disease, Biologics license application, Infection, Trial of the century, Immuron, Pharmaceutical industry

MELBOURNE, Australia, March 07, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce the interim topline results confirming that a single daily dose of Travelan® is effective in prevention of moderate to severe diarrhea following challenge with enterotoxigenic Escherichia coli (ETEC).

Key Points: 
  • This interim analysis summarizes the data for a total of 60 subjects who have completed the inpatient challenge component of this current clinical study.
  • Last patients last visits are anticipated to commence in April this year and final clinical study report will be completed in H2 2024.
  • To learn more about Phase 2 study design, read: U.S. Food and Drug Administration Step 3: Clinical Research
    IMM-124E (Travelan®) will be the first product developed with Immuron’s platform technology to proceed into Phase 3 clinical trials.
  • Immuron is in the process of exploring non-dilutive funding opportunities for these Phase 3 clinical trials.

Immuron Presentation Australian Biologics Festival 2024

Retrieved on: 
Wednesday, February 21, 2024
IMC, ASX, Biopharmaceutical, Doctor of Philosophy, Research and development

MELBOURNE, Australia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Research & Development Manager, Joanne Casey, PhD will be presenting at the Australian Biologics Festival 2024 on Wednesday, 21st February in Melbourne, Australia.

Key Points: 
  • MELBOURNE, Australia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Research & Development Manager, Joanne Casey, PhD will be presenting at the Australian Biologics Festival 2024 on Wednesday, 21st February in Melbourne, Australia.
  • A copy of the presentation slide deck is available on the Company’s website.
  • Authorised for release by the Board of Immuron Limited.

IMC Trading Invites Top STEM Students to Compete in Global Trading Challenge

Retrieved on: 
Monday, February 26, 2024
IMC, IMC Global, Student, Prosperity, University, STEM, Video game

AMSTERDAM, Feb. 26, 2024 /PRNewswire/ -- Global market maker IMC today announced the return of its unique market simulation challenge, Prosperity. 'The world's most innovative trading challenge', Prosperity invites STEM university students worldwide to put their trading skills to the test in a virtual tropical island archipelago.

Key Points: 
  • 'The world's most innovative trading challenge', Prosperity invites STEM university students worldwide to put their trading skills to the test in a virtual tropical island archipelago.
  • Students at more than 400 universities across 109 countries took part, with 94% of participants indicating they would now consider a career in trading," said Matthew Rose, Global Marketing Manager at IMC.
  • Reaching Prosperity will require participants to go beyond the obvious – just like a career in trading at IMC."
  • Students currently enrolled at a university and studying a STEM subject can visit prosperity.imc.com to register for the challenge until April 8th.

IMC Trading Invites Top STEM Students to Compete in Global Trading Challenge

Retrieved on: 
Monday, February 26, 2024
IMC, IMC Global, Student, Prosperity, University, STEM, Video game

AMSTERDAM, Feb. 26, 2024 /PRNewswire/ -- Global market maker IMC today announced the return of its unique market simulation challenge, Prosperity. 'The world's most innovative trading challenge', Prosperity invites STEM university students worldwide to put their trading skills to the test in a virtual tropical island archipelago.

Key Points: 
  • 'The world's most innovative trading challenge', Prosperity invites STEM university students worldwide to put their trading skills to the test in a virtual tropical island archipelago.
  • Students at more than 400 universities across 109 countries took part, with 94% of participants indicating they would now consider a career in trading," said Matthew Rose, Global Marketing Manager at IMC.
  • Reaching Prosperity will require participants to go beyond the obvious – just like a career in trading at IMC."
  • Students currently enrolled at a university and studying a STEM subject can visit prosperity.imc.com to register for the challenge until April 8th.

Garmin adds IFR and 4-axis capability to GFC 600H helicopter flight control system

Retrieved on: 
Tuesday, February 20, 2024
Marketing, Aircraft, GFS, Bell, Radar, LVL, Aviation, GMC, GRMN, GFC, SAS, EASA, VFR, AS350, Government, Autopilot, DVE, Safety, Blog, NVG, IMC, Attitude, Mental toughness, Satellite navigation device

OLATHE, Kan., Feb. 20, 2024 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced the GFC™ 600H Helicopter Flight Control System is now available in an IFR configuration with a Stability Augmentation System (SAS). This configuration includes collective control, bringing 4-axis capability to the GFC 600H system for the first time. Leonardo Helicopters' AW109 Trekker is the first platform to incorporate the GFC 600H with IFR and collective axis capabilities, providing operators with an advanced flight control solution that reduces pilot workload and improves mission effectiveness.

Key Points: 
  • OLATHE, Kan., Feb. 20, 2024 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced the GFC™ 600H Helicopter Flight Control System is now available in an IFR configuration with a Stability Augmentation System (SAS).
  • This configuration includes collective control, bringing 4-axis capability to the GFC 600H system for the first time.
  • "We are very excited to now offer a 4-axis, IFR flight control system for the helicopter market.
  • The IFR configuration of the GFC 600H flight control system has received European Union Aviation Safety Agency (EASA) approval on the AW109 Trekker helicopter.

Immuron achieves record Travelan® sales

Retrieved on: 
Tuesday, February 13, 2024
YTD, Growth, ASX, Immuron, Australian Bureau of Statistics, International Trade Administration, IMC, Statistics, McKesson Corporation, Uranium mining

MELBOURNE, Australia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce record sales (unaudited net sales) of Travelan®, an over-the-counter immune supplement that targets pathogenic bacteria and the toxins they produce in the gastrointestinal (GI) tract.

Key Points: 
  • MELBOURNE, Australia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce record sales (unaudited net sales) of Travelan®, an over-the-counter immune supplement that targets pathogenic bacteria and the toxins they produce in the gastrointestinal (GI) tract.
  • Sales of Travelan® increased to AUD $2.1 million YTD Jan 2024 compared to AUD $0.3 million YTD Jan 2023.
  • Flavio Palumbo, Chief Commercial Officer said, “We are excited by the strong sales results on Travelan®.
  • Immuron’s investment to drive awareness of the Travelan® brand has seen strong sales results in Australia over the summer peak travel period.

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Retrieved on: 
Thursday, February 8, 2024
IMC, ASX

MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore will be presenting at the Monsoon Communications Investor function on Thursday, 8th February in Sydney, Australia.

Key Points: 
  • MELBOURNE, Australia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore will be presenting at the Monsoon Communications Investor function on Thursday, 8th February in Sydney, Australia.
  • A copy of the presentation slide deck is available on the Company’s website.
  • Authorized for release by the Board of Immuron Limited.